TY - JOUR T1 - Neonatal jaundice in infants born at 37 weeks: is NICE treating too many? JF - Archives of Disease in Childhood - Fetal and Neonatal Edition JO - Arch Dis Child Fetal Neonatal Ed DO - 10.1136/archdischild-2022-325075 SP - fetalneonatal-2022-325075 AU - Mona Noureldein AU - Chloe Hill AU - Amira Ali AU - Shammah Gbenga-Ojo AU - Morenike Adewuyi AU - Vikki Fradd AU - Pinki Surana Y1 - 2023/02/02 UR - http://fn.bmj.com/content/early/2023/02/02/archdischild-2022-325075.abstract N2 - Neonatal jaundice affects approximately 60% of term and 80% of preterm infants within the first week of life. Gestation-based treatment threshold graphs by the National Institute of Health and Care Excellence are used to guide jaundice management in the UK.1 NICE treatment thresholds at 37-week gestation are much lower compared with ≥38 weeks and also when compared with the previous and recently updated American Academy of Paediatrics guidelines.1–3 This results in an increased treatment burden and hospitalisation of 37-week infants, including mother–baby separation. Infants born at 37 weeks usually are grouped with those born at ≥38 weeks for most neonatal pathologies under the label ‘term infants’. Whether kernicterus develops at a lower serum bilirubin (SBR) level in 37-week infants compared with those ≥38-week … ER -